Panida Ditsawanon

Panida Ditsawanon

Auto-generated profile, based on publicly available information

Panida Ditsawanon

Faculty of Pharmacy, Payap University, Chiang Mai 50000, Thailand

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2024 in Tobacco Induced Diseases
Verified
Journal Article
Open access
PPPantira Parinyarux
Pantira Parinyarux
PDPanida Ditsawanon
Panida Ditsawanon
ACAthichar Chanwuthinun
Athichar Chanwuthinun
AUAdinat Umnuaypornlert
Adinat Umnuaypornlert
SSSurasak Saokaew
Surasak Saokaew
PTPreechaya Tajai
Preechaya Tajai
Introduction: Perceptions, personal perspectives, and public awareness of e-cigarette information have a significant impact on e-cigarette smoking behavior, and provide comprehensive information that can help reduce interest in e-cigarette smoking and reduce the number of new smokers. This...

11 July 2026 in Toxicology Reports
Verified
Journal Article
Open access
PTPreechaya Tajai
Preechaya Tajai
SSSuparada Sawatdikun
Suparada Sawatdikun
TSTapakon Srisopa
Tapakon Srisopa
GKGiatgong Konguthaithip
Giatgong Konguthaithip
PPPantira Parinyarux
Pantira Parinyarux
PCPiyapan Charoensook
Piyapan Charoensook
The increasing use of electronic cigarettes (e-cigarettes) has raised concerns regarding potential health effects associated with both direct use and secondhand exposure to e-cigarette aerosols. However, human evidence describing systemic metabolic alterations related to these exposures remains limited. In this study, metabolomics was applied to compare urinary metabolic profiles among active e-cigarette users, individuals exposed to secondhand e-cigarette aerosols, and unexposed control participants. Multivariate analyses were performed to identify exposure-related metabolic signatures, followed by pathway enrichment and evaluation of candidate biomarkers. Distinct metabolic differences were observed across exposure groups. Direct e-cigarette use was associated with alterations in amino acid metabolism, mitochondrial energy pathways, and redox-related processes, with glutathione metabolism identified as a key associated pathway and oxidized glutathione highlighted as a candidate urinary biomarker of redox-related metabolic alterations. Secondhand exposure was primarily associated with alterations in alanine, aspartate, and glutamate metabolism, with L-glutamic acid demonstrating discriminatory performance as a candidate metabolite associated with metabolic differences related to secondhand e-cigarette aerosol exposure. Comparative pathway analyses suggested that direct e-cigarette use was associated with more extensive metabolic alterations than secondhand exposure, particularly in pathways linking glutamine-glutamate metabolism, the tricarboxylic acid cycle, and glutathione metabolism, suggesting a possible graded biological response to aerosol exposure. In addition, nicotine metabolism-related metabolites and e-liquid constituents, including propylene glycol, glycerol, and cotinine N-oxide, were identified as candidate urinary exposure biomarkers of e-cigarette exposure. Overall, these findings suggest that e-cigarette aerosol exposure may be associated with measurable metabolic responses, even at indirect exposure levels, and highlight the potential utility of metabolomics as an approach for identifying both exposure biomarkers and biomarkers of biological effect.